Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Complementary and alternative medicine: opportunities and challenges for cancer management and research.

Richardson MA, Straus SE.

Semin Oncol. 2002 Dec;29(6):531-45. Review.

PMID:
12516036
3.

Research on complementary and alternative medicine using randomized controlled trials.

Harlan WR Jr.

J Altern Complement Med. 2001;7 Suppl 1:S45-52. Review.

PMID:
11822635
4.
5.
6.
7.
8.

Approaching complementary and alternative medicine use in patients with cancer: questions and challenges.

Ben-Arye E, Frenkel M, Margalit RS.

J Ambul Care Manage. 2004 Jan-Mar;27(1):53-62. Review.

PMID:
14717464
9.

Complementary and alternative medicine. Considering the alternatives.

Weber DO.

Physician Exec. 1998 Nov-Dec;24(6):6-14.

PMID:
10351720
10.

Advising patients on the use of complementary and alternative medicine.

Jonas WB.

Appl Psychophysiol Biofeedback. 2001 Sep;26(3):205-14.

PMID:
11680284
11.

The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.

Kantor M.

J Am Coll Radiol. 2009 Apr;6(4):254-62. doi: 10.1016/j.jacr.2008.09.012.

PMID:
19327658
12.

State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop.

Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK.

Circulation. 2001 Apr 24;103(16):2038-41.

13.

National Cancer Institute's OCCAM partners with NCCAM to expand research on unconventional cancer treatments.

Muscat M.

Altern Ther Health Med. 1999 Jul;5(4):26-30. No abstract available.

PMID:
10394671
14.

Complementary and alternative cancer medicine.

Cassileth BR.

J Clin Oncol. 1999 Nov;17(11 Suppl):44-52. Review. No abstract available.

PMID:
10630262
15.

The use of complementary and alternative therapies.

Corless IB, Abrams D, Nicholas PK, McGibbon CA.

AACN Clin Issues. 2000 Feb;11(1):4-6.

PMID:
11040547
16.

Complementary and alternative therapeutics: rigorous research is needed to support claims.

Kinsel JF, Straus SE.

Annu Rev Pharmacol Toxicol. 2003;43:463-84. Epub 2002 Jan 10. Review.

PMID:
12540748
17.

Best case series 'SWAT' teams: AHRQ/NCCAM/RAND partnership facilitates review of CAM cancer treatments.

Muscat M.

Altern Ther Health Med. 2001 Sep-Oct;7(5):24-6. No abstract available.

PMID:
11565398
18.

Challenges to complementary and alternative medical research: focal issues influencing integration into a cancer care model.

Giordano J, Engebretson J, Garcia MK.

Integr Cancer Ther. 2005 Sep;4(3):210-8. Review.

PMID:
16113028
19.

Mapping patterns of complementary and alternative medicine use in cancer: an explorative cross-sectional study of individuals with reported positive "exceptional" experiences.

Hök J, Tishelman C, Ploner A, Forss A, Falkenberg T.

BMC Complement Altern Med. 2008 Aug 8;8:48. doi: 10.1186/1472-6882-8-48.

20.

Complementary and alternative medicine research and cooperative groups: can it happen?

O'Mara A.

J Pediatr Oncol Nurs. 2006 Sep-Oct;23(5):258-60.

PMID:
16902079

Supplemental Content

Support Center